Fosun Pharmaceutical Layout Respiratory Medicine Business

Pharmaceutical son,""i." LLC (PBM) will remain in the remaining 20%Goldcup was established in Sweden in 2017 as a new company to restructure the investment target of the transaction, and BEFORE the closing of the transaction, PBM transferred all of the Breas device business related companies to GoldcupHeadquartered in Gothenburg, Sweden, Breas is a specialist medical device company that develops, manufactures and markets the treatment of sleep respiratory diseases and chronic obstructive pulmonary disease, has a European brand of high-quality and high-performance ventilators and has established a proven sales network in Europe and the United Statesventilators are primarily used to treat chronic obstructive pulmonary disease and sleep apnea syndromeChronic obstructive pulmonary disease (COPD) is a chronic bronchitis and/or emphysema characterized by air flow obstruction, which can be further developed into a common chronic disease of pulmonary heart disease and respiratory failure, and the quality of air directly affects the incidence of the disease and threatens thehealth;As Chinese society has become increasingly concerned about respiratory health anddiseasestreatment, FosunMedicinescontinue to develop respiratory areas and enrich product lines, providing innovative solutions for patients with respiratory diseases through business platforms and professional channelsIn 2016, Fosun Pharma accelerated the commercialization of its first product, Fenom PRO™ portable asthma detector, through Spirometrix, a Silicon Valley asthma monitoring technology company, and partnered with The Independent to establish a joint venture with The Independent in Shanghaitoto develop and sell tools for early diagnosis and treatment of lung cancerAfter the completion of this transaction, in the field of respiratory medicine, Fosun Pharma will form a strategic platform from the early diagnosis of lung cancer, asthma, to the treatment of common respiratory diseases of equipment products, and gradually build Fosun Pharma's respiratory medicine industry closed loopFosun Pharmaceutical management said that the transaction is conducive to enhance fosun pharmaceuticalmedical device research and development strength, enrich the medical device product line, and help Fosun Pharma to cover the global network of integrated medical device operating platform (